跳至主要内容
临床试验/NCT04997590
NCT04997590Unknown不适用

Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in Promoting Traumatic Fracture Healing

Qianfoshan Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
1
主要终点
Bone defect connection

研究概览

简要总结

The aim of this study is to explore the effectiveness and safety of umbilical cord blood mononuclear cells in promoting traumatic fracture healing.

详细描述

Umbilical cord blood mononuclear cells are a type of cell group containing hematopoietic stem cells, mesenchymal stem cells, neural stem cells, endothelial cells, immune cells, etc.In this study ,umbilical cord blood mononuclear cells will be used in promoting traumatic fracture healing,and the effectiveness and safety of the treatment plan was evaluated by twelve months of follow-up after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Traumatic long bone fracture.
  • Noninfectious bone nonunion, delayed bone union.
  • 3 months after the operation of the fracture, the examination showed no callus growth, no signs of progressive repair at the fracture site, fracture piece space < 5mm.
  • No shortening, angulation and displacement.
  • There was no obvious callus growth 8 months after local bone grafting.

排除标准

  • There are infection foci at and near the fracture end after fracture.
  • 3 months after the fracture, tests showed partial callus growth.
  • Combining shortening, angulation and displacement phenomena.
  • Partial callus grew 8 months after local bone grafting.

研究组 & 干预措施

Umbilical cord blood mononuclear cells group

Experimental

Umbilical cord blood mononuclear cells (cell number 1×108/2mL), once every two weeks, 3 times in total.

干预措施: Umbilical cord blood mononuclear cells (Biological)

Staphylococcal Enterotoxin C group

Active Comparator

Staphylococcal enterotoxin C (2mL), once every two weeks, 3 times in total.

干预措施: Staphylococcal Enterotoxin C (Drug)

结局指标

主要结局

Bone defect connection

时间窗: 1 month to 1 year after treatment

0 points for complete fracture lines, 2 points for partial fracture lines, 4 points for lack of fracture lines.

Bone formation

时间窗: 1 month to 1 year after treatment

If there is no bone formation, 0 points. Bone formation accounts for 25% of the fracture area, 1 point. Bone formation accounts for 50% of the fracture area, 2 points. Bone formation accounts for 75% of the fracture area, 3 points. Bone filled the gap between fracture ends, 4 points.

Bone reconstruction

时间窗: 1 month to 1 year after treatment

0 points for no manifestations of reconstruction,2 points for intramedullary cavity can be reconstructed , and 4 points for the cortical bone can be completely reconstructed. A total score of 11 points or more achieves a good healing effect.

次要结局

未报告次要终点

研究者

发起方
Qianfoshan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lili Cao

Professor

Qianfoshan Hospital

研究点 (1)

Loading locations...

相似试验